Literature DB >> 22621786

Functional dissociation between PIKfyve-synthesized PtdIns5P and PtdIns(3,5)P2 by means of the PIKfyve inhibitor YM201636.

Diego Sbrissa1, Ognian C Ikonomov, Catherine Filios, Khortnal Delvecchio, Assia Shisheva.   

Abstract

PIKfyve is an essential mammalian lipid kinase with pleiotropic cellular functions whose genetic knockout in mice leads to preimplantation lethality. Despite several reports for PIKfyve-catalyzed synthesis of phosphatidylinositol 5-phosphate (PtdIns5P) along with phosphatidylinositol-3,5-biphosphate [PtdIns(3,5)P(2)] in vitro and in vivo, the role of the PIKfyve pathway in intracellular PtdIns5P production remains underappreciated and the function of the PIKfyve-synthesized PtdIns5P pool poorly characterized. Hence, the recently discovered potent PIKfyve-selective inhibitor, the YM201636 compound, has been solely tested for inhibiting PtdIns(3,5)P(2) synthesis. Here, we have compared the in vitro and in vivo inhibitory potency of YM201636 toward PtdIns5P and PtdIns(3,5)P(2). Unexpectedly, we observed that at low doses (10-25 nM), YM201636 inhibited preferentially PtdIns5P rather than PtdIns(3,5)P(2) production in vitro, whereas at higher doses, the two products were similarly inhibited. In cellular contexts, YM201636 at 160 nM inhibited PtdIns5P synthesis twice more effectively compared with PtdIns(3,5)P(2) synthesis. In 3T3L1 adipocytes, human embryonic kidney 293 and Chinese hamster ovary (CHO-T) cells, levels of PtdIns5P dropped by 62-71% of the corresponding untreated controls, whereas those of PtdIns(3,5)P(2) fell by only 28-46%. The preferential inhibition of PtdIns5P versus PtdIns(3,5)P(2) at low doses of YM201636 was explored to probe contributions of the PIKfyve-catalyzed PtdIns5P pool to insulin-induced actin stress fiber disassembly in CHO-T cells, GLUT4 translocation in 3T3L1 adipocytes, and induction of aberrant cellular vacuolation in these or other cell types. The results provide the first experimental evidence that the principal pathway for PtdIns5P intracellular production is through PIKfyve and that insulin effect on actin stress fiber disassembly is mediated entirely by the PIKfyve-produced PtdIns5P pool.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22621786      PMCID: PMC3422984          DOI: 10.1152/ajpcell.00105.2012

Source DB:  PubMed          Journal:  Am J Physiol Cell Physiol        ISSN: 0363-6143            Impact factor:   4.249


  59 in total

Review 1.  PIKfyve: Partners, significance, debates and paradoxes.

Authors:  Assia Shisheva
Journal:  Cell Biol Int       Date:  2008-01-25       Impact factor: 3.612

2.  ArPIKfyve homomeric and heteromeric interactions scaffold PIKfyve and Sac3 in a complex to promote PIKfyve activity and functionality.

Authors:  Diego Sbrissa; Ognian C Ikonomov; Homer Fenner; Assia Shisheva
Journal:  J Mol Biol       Date:  2008-10-11       Impact factor: 5.469

3.  Cutting edge: Dok-1 and Dok-2 adaptor molecules are regulated by phosphatidylinositol 5-phosphate production in T cells.

Authors:  Geoffrey Guittard; Audrey Gérard; Sophie Dupuis-Coronas; Hélène Tronchère; Eva Mortier; Cédric Favre; Daniel Olive; Pascale Zimmermann; Bernard Payrastre; Jacques A Nunès
Journal:  J Immunol       Date:  2009-04-01       Impact factor: 5.422

4.  Loss of Vac14, a regulator of the signaling lipid phosphatidylinositol 3,5-bisphosphate, results in neurodegeneration in mice.

Authors:  Yanling Zhang; Sergey N Zolov; Clement Y Chow; Shalom G Slutsky; Simon C Richardson; Robert C Piper; Baoli Yang; Johnathan J Nau; Randal J Westrick; Sean J Morrison; Miriam H Meisler; Lois S Weisman
Journal:  Proc Natl Acad Sci U S A       Date:  2007-10-23       Impact factor: 11.205

Review 5.  PI3K pathway alterations in cancer: variations on a theme.

Authors:  T L Yuan; L C Cantley
Journal:  Oncogene       Date:  2008-09-18       Impact factor: 9.867

Review 6.  Phosphoinositides in insulin action on GLUT4 dynamics: not just PtdIns(3,4,5)P3.

Authors:  Assia Shisheva
Journal:  Am J Physiol Endocrinol Metab       Date:  2008-05-20       Impact factor: 4.310

7.  Type I phosphatidylinositol-4,5-bisphosphate 4-phosphatase regulates stress-induced apoptosis.

Authors:  Jun Zou; Jasna Marjanovic; Marina V Kisseleva; Monita Wilson; Philip W Majerus
Journal:  Proc Natl Acad Sci U S A       Date:  2007-10-16       Impact factor: 11.205

8.  Elevated levels of PtdIns5P in NPM-ALK transformed cells: implication of PIKfyve.

Authors:  S Coronas; F Lagarrigue; D Ramel; G Chicanne; G Delsol; B Payrastre; H Tronchère
Journal:  Biochem Biophys Res Commun       Date:  2008-05-22       Impact factor: 3.575

Review 9.  Function and dysfunction of the PI system in membrane trafficking.

Authors:  Mariella Vicinanza; Giovanni D'Angelo; Antonella Di Campli; Maria Antonietta De Matteis
Journal:  EMBO J       Date:  2008-09-11       Impact factor: 11.598

10.  A selective PIKfyve inhibitor blocks PtdIns(3,5)P(2) production and disrupts endomembrane transport and retroviral budding.

Authors:  Harold B J Jefferies; Frank T Cooke; Parmjit Jat; Christine Boucheron; Tomonobu Koizumi; Masahiko Hayakawa; Hiroyuki Kaizawa; Takahide Ohishi; Paul Workman; Michael D Waterfield; Peter J Parker
Journal:  EMBO Rep       Date:  2008-01-11       Impact factor: 8.807

View more
  35 in total

Review 1.  Phosphatidylinositol 3,5-bisphosphate: low abundance, high significance.

Authors:  Amber J McCartney; Yanling Zhang; Lois S Weisman
Journal:  Bioessays       Date:  2013-10-28       Impact factor: 4.345

Review 2.  Polyphosphoinositide-Binding Domains: Insights from Peripheral Membrane and Lipid-Transfer Proteins.

Authors:  Joshua G Pemberton; Tamas Balla
Journal:  Adv Exp Med Biol       Date:  2019       Impact factor: 2.622

3.  The PIKfyve complex regulates the early melanosome homeostasis required for physiological amyloid formation.

Authors:  Christin Bissig; Pauline Croisé; Xavier Heiligenstein; Ilse Hurbain; Guy M Lenk; Emily Kaufman; Ragna Sannerud; Wim Annaert; Miriam H Meisler; Lois S Weisman; Graça Raposo; Guillaume van Niel
Journal:  J Cell Sci       Date:  2019-02-28       Impact factor: 5.285

4.  Plentiful PtdIns5P from scanty PtdIns(3,5)P2 or from ample PtdIns? PIKfyve-dependent models: Evidence and speculation (response to: DOI 10.1002/bies.201300012).

Authors:  Assia Shisheva; Diego Sbrissa; Ognian Ikonomov
Journal:  Bioessays       Date:  2014-11-18       Impact factor: 4.345

5.  Lysosome enlargement during inhibition of the lipid kinase PIKfyve proceeds through lysosome coalescence.

Authors:  Christopher H Choy; Golam Saffi; Matthew A Gray; Callen Wallace; Roya M Dayam; Zhen-Yi A Ou; Guy Lenk; Rosa Puertollano; Simon C Watkins; Roberto J Botelho
Journal:  J Cell Sci       Date:  2018-05-21       Impact factor: 5.285

6.  Toll-like receptor 9 trafficking and signaling for type I interferons requires PIKfyve activity.

Authors:  Kachiko Hayashi; Miwa Sasai; Akiko Iwasaki
Journal:  Int Immunol       Date:  2015-04-29       Impact factor: 4.823

7.  Host PI(3,5)P2 activity is required for Plasmodium berghei growth during liver stage infection.

Authors:  Carolina Thieleke-Matos; Mafalda Lopes da Silva; Laura Cabrita-Santos; Cristiana F Pires; José S Ramalho; Ognian Ikonomov; Elsa Seixas; Assia Shisheva; Miguel C Seabra; Duarte C Barral
Journal:  Traffic       Date:  2014-08-21       Impact factor: 6.215

8.  Muscle-specific Pikfyve gene disruption causes glucose intolerance, insulin resistance, adiposity, and hyperinsulinemia but not muscle fiber-type switching.

Authors:  Ognian C Ikonomov; Diego Sbrissa; Khortnal Delvecchio; Han-Zhong Feng; Gregory D Cartee; Jian-Ping Jin; Assia Shisheva
Journal:  Am J Physiol Endocrinol Metab       Date:  2013-05-14       Impact factor: 4.310

9.  cdc-like/dual-specificity tyrosine phosphorylation-regulated kinases inhibitor leucettine L41 induces mTOR-dependent autophagy: implication for Alzheimer's disease.

Authors:  Xavier Fant; Emilie Durieu; Gaëtan Chicanne; Bernard Payrastre; Diego Sbrissa; Assia Shisheva; Emmanuelle Limanton; François Carreaux; Jean-Pierre Bazureau; Laurent Meijer
Journal:  Mol Pharmacol       Date:  2013-12-23       Impact factor: 4.436

10.  In vivo, Pikfyve generates PI(3,5)P2, which serves as both a signaling lipid and the major precursor for PI5P.

Authors:  Sergey N Zolov; Dave Bridges; Yanling Zhang; Wei-Wei Lee; Ellen Riehle; Rakesh Verma; Guy M Lenk; Kimber Converso-Baran; Thomas Weide; Roger L Albin; Alan R Saltiel; Miriam H Meisler; Mark W Russell; Lois S Weisman
Journal:  Proc Natl Acad Sci U S A       Date:  2012-10-09       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.